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In Brief
Habbeddine et al. show that RANK
signaling in the spleen marginal zone
plays an important role in orchestrating
protective immune responses to viral
infection. They show that RANK
expressed by macrophages supports
viral replication, while RANK signaling in
dendritic cells promotes the recruitment
and activation of memory CD8 T cells.
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The spleen plays an important role in protective
immunity to bloodborne pathogens. Macrophages
and dendritic cells (DCs) in the spleen marginal
zone capture microbial antigens to trigger adaptive
immune responses. Marginal zone macrophages
(MZMs) can also act as a replicative niche for intra-
cellular pathogens, providing a platform formounting
the immune response. Here, we describe a role for
RANK in the coordinated function of antigen-pre-
senting cells in the spleen marginal zone and trig-
gering anti-viral immunity. Targeted deletion of
RANK results in the selective loss of CD169+
MZMs, which provide a niche for viral replication,
while RANK signaling in DCs promotes the recruit-
ment and activation of anti-viral memory CD8
T cells. These studies reveal a role for the RANKL/
RANK signaling axis in the orchestration of protec-
tive immune responses in the spleen marginal zone
that has important implications for the host response
to viral infection and induction of acquired immunity.
INTRODUCTION
Activation of memory CD8 T cells (mCTLs) is critical for protec-
tive immunity against intracellular pathogens such as viruses.
Although memory T cells have an intrinsic capacity to respond
rapidly upon secondary infection (Zhang and Bevan, 2011), trig-
gering of memory cells in secondary lymphoid organs still
requires the activity of professional antigen-presenting cells
such as dendritic cells (DCs) (Alexandre et al., 2016; Zammit
et al., 2005). mCTLs also occupy frontline niches, such as the
spleen marginal zone (MZ), whereas naive T cells are confined
to the follicular T cell zone (Schenkel et al., 2014). The spleen
MZ is populated by antigen-presenting cells, including macro-
phages and DCs, that are strategically placed to capture patho-
gens and antigens from the blood (Martinez-Pomares andCell Repor
This is an open access article undGordon, 2012). Macrophages at the inner MZ, in direct contact
with the marginal sinus and blood flow, are marked by expres-
sion of the lectin-like adhesion molecule Siglec-1 (CD169) and
have been shown to play an important role in trapping immune
complexes and antigen transfer to B cells (Martinez-Pomares
and Gordon, 2012). Previous studies have shown that CD169-
expressing cells can also promote the activation of CD8 T cells
in certain contexts, implying a potential role in cell-mediated im-
munity. The specific ablation of CD169-expressing cells was
shown to prevent cross-presentation of cell-associated viral
and tumor antigens to CD8 T cells (Asano et al., 2011; Bernhard
et al., 2015). Other studies have shown that antigen specifically
targeted to CD169+ cells can be transferred to CD8a-type DCs
(DC1) in the spleen for cross-presentation to CD8 T cells (Backer
et al., 2010). In the context of infection, CD169+ MZ macro-
phages (MZMs) can be permissive for certain intracellular path-
ogens and form a restricted niche for replication, providing a
platform for mounting both cell-mediated and humoral immune
responses (Honke et al., 2011). In fact, CD169 itself has been
shown to be a receptor for virus entry through binding to gangli-
osides in the viral envelope (Hammonds et al., 2017; Sewald
et al., 2015). These studies suggest that CD169+ MZMs, as
well as DCs, can have important roles in CD8 T cell responses
and cell-mediated immunity to bloodborne pathogens. How-
ever, the molecular mechanisms that regulate the coordinated
function of these antigen-presenting cells and help orchestrate
the protective immune response remain poorly understood.
Tumor necrosis factor (TNF) family cytokines lymphotoxin (LT),
RANKL (TRANCE; TNFSF11), and TNF-a have important roles in
the development of secondary lymphoid organs. Mice deficient
in LT or RANKL signaling lack lymph nodes and have severe de-
fects in the spleenmicroarchitecture (Weih andCaaman˜o, 2003).
These defects are due to the loss of LT- and RANKL-mediated
signaling cross-talk between hematopoietic lymphoid tissue
inducer cells (LTis) and stromal lymphoid tissue organizer cells
(LTos) during lymph node (LN) and spleen development (Brendo-
lan and Caaman˜o, 2012; White et al., 2007). In adult mice,
RANKL remains constitutively expressed by marginal reticular
stromal cells (MRCs) (Jarjour et al., 2014; Katakai et al., 2008),
which could be considered the adult equivalent of LTos. MRCsts 21, 2515–2527, November 28, 2017 ª 2017 The Author(s). 2515
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. RANK Expression Does Not Affect DC Survival or Longevity
(A) Gating strategy for RANK+ DCs; representative fluorescence-activated cell sorting (FACS) plots are shown.
(B) Proportion of RANK+ DCs (MHC-IIhi CD11c+ cells) among immune cells in different organs (CLN, cutaneous LN; MLN, mesenteric LN; PP, Peyer’s patches).
(C) Number of RANK+ DCs in CLN from Tnfrsf11af/f and Tnfrsf11aDItgax mice.
(D) Total numbers of DCs in LN and spleen.
(E) Proportions of DC1, DC2, and pDC subsets in CLN and spleen.
(F) Relative numbers of resident DCs (resDC) and migratory DCs (migDC) in CLN.
(G) Lethally irradiated CD45.1+ mice were reconstituted with a 1:1 mix of bone marrow cells from either Tnfrsf11af/f or Tnfrsf11aDItgax mice (donor; CD45.2+) and
wild-type cells from CD45.2+/CD45.1+ mice (competitor). BrdU incorporation by MHC-IIhi CD11c+ cells was measured in CLN from chimeric mice by flow
cytometry; the ratio of BrdU+ resDCs and migDCs from donor (Tnfrsf11af/f and Tnfrsf11aDItgax) and competitor cells is shown.
(legend continued on next page)
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line the marginal sinuses of the spleen and LNs juxtaposed with
CD169+ macrophages, but their function remains unclear. LT
expression by B cells has been shown to be an important matu-
ration signal for CD169+ macrophages in LNs (Phan et al., 2009).
In the absence of B cell-derived LT, there is a dramatic loss of
CD169+ expression in the LN sub-capsular sinus (Iannacone
et al., 2010; Moseman et al., 2012). RANK has been suggested
to play a role in DC survival and longevity during the immune
response (Josien et al., 1999, 2000; Kool et al., 2011), but the
role of RANKL/RANK signaling in the development and function
of MZM has not been studied.
Here, we have addressed the role of RANK signaling in macro-
phages and DCs during the priming and activation of mCTLs in
the context of infection. We generated mice with targeted dele-
tion of RANK (Tnfrsf11a) in DCs and demonstrate that RANK
signaling is redundant for priming naive CD8 T cells but is specif-
ically required for activation of mCTLs in response to viral infec-
tion. The role of RANK in mCTL activation is 2-fold; RANK
expression in CD169+MZMs provides a niche for early viral repli-
cation during secondary infection. The loss of CD169+ MZMs
upon RANK deletion leads to impaired viral replication and the
acquisition of viral antigen by cross-presenting DCs. However,
RANK expression in DCs is also required to promote the recruit-
ment and activation of pathogen-specific mCTLs. These studies
reveal an important role for the RANKL/RANK signaling axis in
the orchestration of protective immune responses in the spleen
MZ and the host response to viral infection.
RESULTS
RANK Expression Does Not Affect DC Survival or
Longevity
RANK is widely expressed among macrophages and DCs at the
mRNA level (https://www.immgen.org; biogps.org). To deter-
mine the intrinsic roles of RANK signaling in these cells, we
generated mice with a targeted deletion of RANK (Tnfrsf11a) in
CD11c-expressing cells by intercrossing Tnfrsf11af/f mice
(Hanada et al., 2009) and Tg(Itgax-Cre) mice (Caton et al.,
2007). Cre expression in these mice is targeted to DCs and
certain macrophage populations that express CD11c, but not
CD11c-negative monocyte/macrophage populations (Caton
et al., 2007; Farrell et al., 2015). Tnfrsf11aDItgax/DItgax mice
(Tnfrsf11aDItgax) were born at normal Mendelian ratios and devel-
oped to adulthood, in contrast to mice with a germline deletion in
RANK (Tnfrsf11a/) that were severely runted at 3 weeks of age
due to defects in tooth eruption and development (Li et al., 2000).
We confirmed the deletion of RANK expression in CD11c+ cells
from Tnfrsf11aDItgax mice by flow cytometry (Figures 1A–1C). No
perturbations in absolute numbers of myeloid or lymphoid cells
were observed in naive Tnfrsf11aDItgax mice compared to litter-
mate controls (data not shown).
Previous studies have suggested that RANK expression by
DCs increased their survival and longevity and, thus, T cell prim-(H) Proportion of RANK+ DCs in CLN from wild-type mice with or without IMQ tr
(I) Proportion of RANK+ DCs in CLN from Tnfrsf11af/f and Tnfrsf11aDItgax mice aft
(J) Quantification of total DC numbers in CLN from Tnfrsf11af/f and Tnfrsf11aDItga
Data are represented as mean ± SEM of nR 3 and are representative of at leasing during the immune response (Josien et al., 2000). Flow
cytometry analysis revealed no differences in DC number in
LNs or spleen from Tnfrsf11aDItgax mice compared to littermate
controls at steady state (Figure 1D). Furthermore, the propor-
tions of the major DC subsets—CD8a-type DC (DC1), CD11b-
type DC (DC2), and pDC—remained unaltered (Figure 1E);
detailed gating strategies are shown in Figure S1. DCmaturation
in steady state can be measured by the migration of tissue-resi-
dent DCs to draining LNs, which is also associated with the
upregulation of RANK expression (Baratin et al., 2015; Dalod
et al., 2014); however, accumulation of migratory DCs in cuta-
neous LNswas also not altered inTnfrsf11aDItgaxmice (Figure 1F).
To further test the intrinsic role of RANK in DC survival and
homeostasis, we performed competitive bone marrow (BM)
chimera experiments. BM cells from Tnfrsf11aDItgax and
Tnfrsf11af/f mice (CD45.2+) were mixed 1:1 with BM cells from
CD45.1+/CD45.2+ mice and then adoptively transferred to
lethally irradiated CD45.1+ recipients. Eight weeks following
adoptive transfer, chimeric mice were exposed to the thymidine
analog bromodeoxyuridine (BrdU) in drinking water for 8 days,
after which LNs were harvested for flow-cytometric analysis of
BrdU incorporation by DCs. The proportions of both resident
and migratory cells and incorporation of BrdU was equal among
DCs derived from Tnfrsf11aDItgax or Tnfrsf11af/f BM cells (Fig-
ure 1G), indicating no intrinsic defect in DC survival or longevity
in steady state. To test the role of RANK in DC homeostasis dur-
ing inflammation, we used topical application of the TLR7/8
agonist imiquimod (Aldara cream containing 5% Imiquimod;
IMQ), a clinically used immune adjuvant (van der Fits et al.,
2009). IMQ treatment dramatically increased the number of
RANK+ DCs in draining LNs and significantly increased the level
of RANK expression (Figure 1H). However, when we compared
the total numbers of DCs in LNs after IMQ treatment, there
was no difference in the absence of RANK expression
(Figures 1I and 1J). These data clearly showed that RANK dele-
tion did not affect the survival of DCs in steady state or during
inflammation.
RANK Expression in CD11c+ Cells Regulates mCTL
Activation in Response to Viral Infection
To test the role of RANK expression in CD11c+ cells for T cell
priming during infection, we used a recombinant strain of the
intracellular bacteria Listeria monocytogenes engineered to
express ovalbumin (Lm-OVA) (Baje´noff et al., 2010) and an
OVA-expressing strain of vesicular stomatitis virus (VSV-OVA)
(Kim et al., 1998). We infected Tnfrsf11af/f and Tnfrsf11aDItgax
mice intravenously (i.v.) with 104 colony-forming units (CFUs) of
Lm-OVA or 105 plaque-forming units (PFUs) of VSV-OVA and
measured the priming of pathogen-specific CD8 T cells. Eight
days after primary infection, the expansion of OVA-specific
CD8 T cells was measured in blood by flow cytometry, using
OVA-specific major histocompatibility complex (MHC) class I
tetramers (H2KbSIINFEKL; Tet). The frequency of Tet+ CD8eatment.
er IMQ treatment; representative FACS plots are shown.
x mice 2 days after IMQ treatment.
t 2 independent experiments.
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T cells and intracellular interferon (IFN)g production after stimu-
lation with cognate peptide was comparable between
Tnfrsf11af/f and Tnfrsf11aDItgax mice (Figures 2A and 2B). Simi-
larly, granzyme B (GrzB) expression by OVA-specific CD8
T cells was unaltered in Tnfrsf11aDItgax mice (Figure S2A). These
data demonstrate that RANK expression by CD11c+ cells was
not required for priming naive CD8 T cells. Conventional DCs
are characterized by their unique roles in priming naive T cells
(Steinman, 2008), but CD11c-expressing cells have also been
shown to be required for triggering mCTLs upon secondary
infection (Zammit et al., 2005). To test the role of RANK expres-
sion during mCTL activation, we immunized cohorts of
Tnfrsf11af/f and Tnfrsf11aDItgax mice with Lm-OVA, VSV-OVA,
or IMQ/OVA and waited 2 months for the contraction of effector
T cell responses and the generation of mCTLs. We then chal-
lenged mice with VSV-OVA or Lm-OVA to trigger the activation
of mCTLs (Figures 2C–2F); Lm-OVA or IMQ/OVA immunized
Tnfrsf11aDItgax mice showed a significant impairment in mCTL
activation upon infection with VSV-OVA, compared with litter-
mate controls, as indicated by reduced expansion of OVA-spe-
cific CD8 T cells in the spleen (Figures 2C, 2D, and S2B). In
contrast, Lm-OVA or VSV-OVA immunized Tnfrsf11aDItgax mice
showed no defect in mCTL activation in response to infection
with Lm-OVA (Figures 2E, 2F, and S2C). These data showed
that RANK expression in CD11c+ cells was specifically required
for triggering mCTLs in response to VSV infection and was
redundant for mCTL activation by Lm. We observed no differ-
ences in the recall of mCTLs harvested from IMQ/OVA or Lm-
OVA immunized Tnfrsf11aDItgax mice ex vivo in the presence of
cognate peptide (Figure S3), indicating that development of
pathogen-specific mCTLs was not affected by RANK deletion
in CD11c-expressing cells. To determine whether RANK expres-
sion in antigen-presenting cells affected the programming of
mCTLs during the primary immune response, we infected con-
genic CD45.1+ mice with Lm-OVA and, 3 weeks later, adoptively
transferred splenic T cells (CD4 and CD8) to naive Tnfrsf11af/f
and Tnfrsf11aDItgax mice (CD45.2+). Based on tetramer staining
prior to adoptive transfer, we estimate that approximately
5,000 OVA-specific effector-mCTL were injected per mouse.
We then waited a further 7 weeks and challenged mice with
VSV-OVA or Lm-OVA to activate adoptively transferred mCTLs
(CD45.1+) (Figure 2G). Subsequent flow cytometry analysis of
VSV-OVA-challenged mice showed a clear defect in expansion
of CD45.1+mCTLs in Tnfrsf11aDItgaxmice compared to littermate
controls (Figures 2H and S4A); however, there was no defect in
the priming of naive endogenous CD8 T cells (CD45.2+). In
contrast, mice challenged with Lm-OVA showed no defect in
the expansion or activation of CD45.1+ mCTLs (Figures 2I and
S4B) and the priming of naive endogenous CD8 T cells
(CD45.2+). These experiments confirmed that RANK expression
in CD11c+ cells is required for the triggering of mCTLs upon
infection with VSV and not the priming or functional program-
ming of memory cells during the primary immune response.
RANK Is Required for Accumulation of CD169+ MZMs
After intravenous infection, mCTLs are activated in the spleen
MZ and inter-follicular regions of the red pulp, whereas naive
T cells are primed in the follicular T cell zone of the white pulp2518 Cell Reports 21, 2515–2527, November 28, 2017(Schenkel et al., 2014). Furthermore, VSV and Lm have been re-
ported to occupy distinct cellular niches for replication within the
spleen, with VSV being restricted to CD169+ MZM (Honke et al.,
2011), whereas Lm specifically targets migratory DC1 and repli-
cates in the T cell zone of the white pulp (Edelson et al., 2011).
RANK ligand (RANKL; TNFSF11) has also been shown to be
constitutively expressed by MRCs that line the spleen MZ (Jar-
jour et al., 2014; Katakai et al., 2008), in direct contact with
CD169+ MZMs. Given that VSV specifically targets CD169+
MZMs and the distinctive expression of RANKL in this niche,
we reasoned that RANK signaling may have a role in the devel-
opment or function of these cells. To test this hypothesis, we first
confirmed expression of RANKL by MRCs in the spleen MZ by
confocal microscopy, which was unaltered in Tnfrsf11aDItgax
mice (Figure 3A). We then assessed the impact of RANK deletion
on MZMs; there was an obvious reduction in non-specific
esterase staining in the MZ of spleens from Tnfrsf11aDItgax
mice compared to littermate controls—a distinctive marker of
metallophilic MZMs (Figure 3B). Furthermore, there was also a
significant reduction in CD169+ cells in the MZ of Tnfrsf11aDItgax
mice, whereas CD209b (SIGN-R1)+ macrophages in the outer
MZ were unaffected (Figures 3C and 3D). The close proximity
of RANKL+ MRCs and CD169+ MZMs suggested that intrinsic
RANK signaling could be required to maintain CD169-express-
ing cells. Previous studies have shown that CD11c is expressed
by at least a subset of CD169+ cells in the MZ (Farrell et al., 2015;
Probst et al., 2005); to confirm targeting of CD169+ cells in
CD11c-Cre mice, we crossed these mice to Rosa26-lsl-tdRFP
reporter mice (Luche et al., 2007). Analysis of spleen sections
from thesemice by confocal microscopy showed red fluorescent
protein (RFP) expression in a subset of CD169+ cells in the MZ,
as well as cells throughout the white pulp and red pulp of the
spleen (Figure 3E), confirming efficient Cre recombinase activity
in these cells and, thus, targeting of these cells in Tnfrsf11aDItgax
mice. Furthermore, an analysis of spleen sections from Tg(Itgax-
EYFP) mice, which express yellow fluorescent protein (YFP) from
the CD11c promoter, clearly showed that a subset of CD169+
cells in the MZ actively expressed CD11c (Figure 3F). These
data suggested that intrinsic RANK signaling was required for
the maintenance of CD11c+ CD169+ MZMs.
RANK-Dependent MZMs Provide a Niche for VSV
Replication
Since CD169+ MZMs have previously been shown to provide a
restricted replicative niche for VSV (Honke et al., 2011), we
reasoned that loss of RANK-dependent MZMs could affect
VSV replication. To test this hypothesis, we measured viral titers
in spleens harvested from Tnfrsf11aDItgax and Tnfrsf11af/f mice
7 hr after infection with VSV-OVA. There was a significant reduc-
tion in splenic VSV titers from Tnfrsf11aDItgax mice compared to
littermate controls (Figure 4A), which correlated with reduced
expression of virus-encoded OVA, determined by qRT-PCR
with RNA isolated from total splenocytes (Figure 4B). These
data showed that RANK signaling in CD11c-expressing cells
promotes early viral replication and expression of viral antigens
in the spleen. To confirm the restricted replication of VSV in
CD169+ cells in situ, we used a recombinant strain of VSV ex-
pressing GFP (VSV-GFP) and performed confocal microscopy
Figure 2. RANK Expression by CD11c+ Cells Regulates mCTL Activation in Response to Viral Infection
(A andB) Expansion of endogenousOVA-specific CD8 T cells (Tet-H2KbSIINFEKL; Tet+) wasmeasured in peripheral blood from Tnfrsf11af/f and Tnfrsf11aDItgaxmice
1week after infection i.v. with 13 104 CFUs of Lm-OVA (A) or 13 105 PFUs of VSV-OVA (B). IFNg productionwasmeasured by intracellular cytokine staining (ICS)
after ex vivo stimulation with cognate peptide (SIINFEKL).
(C–F) Cohorts of Tnfrsf11af/f and Tnfrsf11aDItgax mice were immunized with Lm-OVA, IMQ/OVA, or VSV-OVA; (C) Lm/ VSV, (D) IMQ/ VSV, (E) Lm/ Lm, and
(F) VSV/ Lm. 2months later, mice were challenged with either VSV-OVA (C and D) or Lm-OVA (E and F). 5 days later, expansion of OVA-specificmCTLs (CD44+
Tet+) was measured in spleen by flow cytometry.
(G–I) Shown in (G): experimental strategy for the adoptive transfer of mCTLs. CD45.1+ mice were immunized with Lm-OVA; 3 weeks later, CD4 and CD8 T cells
were isolated from spleen and adoptively transferred to cohorts of naive Tnfrsf11af/f and Tnfrsf11aDItgax mice. A further 7 weeks after T cell transfer, mice were
infected with VSV-OVA (H) or Lm-OVA (I); activation of adoptively transferred mCTLs (CD44+, CD45.1+) and priming of endogenous naive CD8 T cells (CD45.2+)
were measured simultaneously in spleen 5 days after challenge as expansion of Tet+ cells.
Data are represented as mean ± SEM, and statistical analysis was performed with the Mann-Whitney test; **p < 0.01.
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Figure 3. RANK Is Required for CD11c+
CD169+ MZMs
(A–D) Immunohistochemical analysis of spleen
sections from Tnfrsf11af/f and Tnfrsf11aDItgax mice
analyzed by confocal microscopy. (A) RANKL
staining (red) of marginal reticular stromal cells
(MRCs) in the spleen marginal zone (MZ); CD4
staining for T cells is in blue. (B) Non-specific
esterase staining of spleen sections. (C) CD169
(green; filled arrowheads) and CD209b staining
(red; open arrowheads); B cells are stained with
B220 (blue). (D) Quantification of CD169, CD209b,
and B220 staining in the spleen MZ of Tnfrsf11af/f
and Tnfrsf11aDItgax mice. Data are represented as
the mean intensity (±SEM) within the MZ from nR
3 mice.
(E) Spleen sections from Rosa26-LSL-tdRFP 3
Tg(Itgax-Cre) mice showing Cre-recombinase ac-
tivity in CD169+ cells; red indicates tdRFP, and
green indicates CD169.
(F) Spleen sections from Tg(Itgax-EYFP) mice
showing CD11c expression in CD169+ cells; blue
indicates YFP, green indicates CD169, and red
indicates CD209b. Scale bars: 100 mm in the upper
panels and 25 mm in the lower panels. Represen-
tative micrographs are shown from at least 2 in-
dependent experiments.
Statistical analysis was performed with the Mann-
Whitney test; ****p < 0.0001.(Iannacone et al., 2010). As expected, GFP expression co-local-
ized with CD169+ cells in the spleen MZ after infection with VSV-
GFP, and there was a drastic reduction of GFP+ cells in spleens
harvested from Tnfrsf11aDItgaxmice compared to littermate con-
trols (Figures 4C and 4D); this correlated with a significant reduc-
tion in total VSV-GFP titers (Figure 4E). Recent studies have
shown that cross-presenting DC1 cells, which localize to the
MZ and interfollicular regions of the spleen, are required for full
activation of mCTLs after VSV infection, as well as other patho-
gens, including Lm (Alexandre et al., 2016). Flow cytometry anal-
ysis revealed acquisition of VSV-GFP by splenic DCs—specif-
ically, the DC1 subset (Figure 4F). Furthermore, in keeping with
reduced VSV replication, significantly lower levels of VSV-GFP
were detected in DCs from Tnfrsf11aDItgaxmice (Figure 4G). Total
numbers of splenic DC1 cells were not altered in Tnfrsf11aDItgax
mice (Figure 1), which suggested that the reduced acquisition of
VSV was due to reduced replication in CD169+ MZMs.
To confirm that the reduction in VSV replication was due to the
loss of RANK signaling in CD11c+ MZMs and not DCs, we
crossed Tnfrsf11af/f mice with Lyz2cre/+ mice (Clausen et al.,
1999), which express Cre recombinase in macrophages but
not conventional DCs (Baratin et al., 2015). In keeping with an2520 Cell Reports 21, 2515–2527, November 28, 2017intrinsic role for RANK signaling in
CD169+ MZMs, Tnfrsf11aDLyz2 mice also
showed a significant loss of CD169+ cells
in the MZ, compared to littermate
controls (Figures 5A–5C and S5A).
Furthermore, VSV replication was signifi-
cantly impaired in Tnfrsf11aDLyz2 mice
compared to littermates (Figure 5D).However, the loss of MZMs and reduced viral replication in
Tnfrsf11aDLyz2mice was not sufficient to impair either the priming
or activation of mCTLs in response to VSV infection (Figures 5E
and 5F). We confirmed that RANK expression by DCs was re-
tained in Tnfrsf11aDLyz2 mice, as opposed to Tnfrsf11aDItgax
mice (Figure S5B), suggesting that defective mCTL activation
upon RANK deletion in CD11c+ cells was likely due to the
expression of RANK by DCs. These data showed that RANK
expression by MZMs maintains a replicative niche for VSV and
suggested that RANK expression by DCs was additionally
required to promote mCTL activation.
Collaboration of MZM and DC1 for Activation of mCTLs
Recent studies have shown that DC1 cells are required for full
activation of mCTLs in response to several pathogens, including
VSV (Alexandre et al., 2016). We observed a striking increase in
RANK expression by splenic DCs upon VSV infection of immu-
nized mice (Figure 6A), demonstrating that RANK expression is
upregulated by DCs during mCTL activation. RANK expression
was also strongly induced by DCs in mice treated with the
TLR7/8 agonist IMQ (Figure 1H), indicating that induction of
RANK expression on DCs was a direct consequence of viral
Figure 4. RANK-Dependent MZMs Provide a Niche for VSV Replication
(A and B) Lm-OVA-immunized mice were infected i.v. with VSV-OVA, and spleens were harvested after 7 hr for analysis of viral replication. (A) Splenic titers of
VSV-OVA from immunized Tnfrsf11af/f and Tnfrsf11aDItgax mice. (B) qRT-PCR analysis of OVA expression in total splenocytes.
(C andD) Lm-OVA-immunized Tnfrsf11af/f and Tnfrsf11aDItgaxmicewere challengedwith VSV-GFP. (C) Confocal microscopy of spleen sections 7 hr after infection
with VSV-GFP; viral replication (green) is shown in CD169+ cells in the MZ (red); B cells are stained with B220 (blue). Scale bars: 100 mm in the upper panels and
25 mm in the lower panels. Representative micrographs are shown from at least 2 independent experiments. (D) Quantification of GFP+ CD169+ cells in the MZ.
(E) Splenic titers of VSV-GFP from Tnfrsf11af/f and Tnfrsf11aDItgax mice 7 hr after infection.
(F and G) Flow cytometry analysis of GFP expression in CD8a+ splenic DCs from Lm-OVA-immunized Tnfrsf11af/f and Tnfrsf11aDItgax mice 7 hr after VSV-GFP
infection. Gating strategy (F) and quantification (G) are shown.
Representative FACS plots are shown, and graphs represent mean ± SEM of nR 6. Statistical analysis was performed with the Mann-Whitney test. *p < 0.05;
**p < 0.01; ****p < 0.0001.infection. To directly test the effects of RANK signaling on acti-
vation of CD8 T cells by DCs, we performed co-culture experi-
ments with DCs derived from Tnfrsf11aDItgax and Tnfrsf11af/f
mice and RANKL-expressing stromal cells; in these experi-
ments, RANKL significantly increased the expansion of
antigen-specific CD8 T cells and IFNg production in a RANK-
dependent manner (Figure S6), demonstrating that RANKL/RANK signaling in DCs can enhance CD8 T cell activation in
response to exogenous antigen.
We next assessed the role of RANK in DC activation in vivo
during mCTL activation by VSV. mCTLs patrol the spleen MZ
during recall responses and rapidly form clusters with DCs (Ba-
je´noff et al., 2010; Schenkel et al., 2014). The early recruitment of
mCTLs is driven by the IFNg-dependent induction of CXCL9Cell Reports 21, 2515–2527, November 28, 2017 2521
Figure 5. RANK-Dependent MZMs Are Not Sufficient for mCTL Activation
(A–C) Immunohistochemical analysis of spleen sections from Tnfrsf11af/f and Tnfrsf11aDLyz2 mice analyzed by confocal microscopy; (A) Non-specific esterase
staining of spleen sections. (B) CD169 (green; filled arrowheads) and CD209b staining (red; open arrowheads); B cells are stained with B220 (blue). Scale bars:
100 mm. Representative micrographs are shown from at least 2 independent experiments. (C) Quantification of CD169, CD209b, and B220 staining in the spleen
MZ of Tnfrsf11af/f and Tnfrsf11aDLyz2 mice; data are represented as the mean intensity (±SEM) within the MZ from nR 3 mice.
(D) Tnfrsf11af/f and Tnfrsf11aDLyz2 mice were infected i.v. with 106 PFUs of VSV-GFP, and spleens were harvested after 7 hr for analysis of viral replication.
(E) Expansion of OVA-specific CD8 T cells (Tet+) was measured in blood from Tnfrsf11af/f and Tnfrsf11aDLyz2 mice 8 days after infection i.v. with Lm-OVA or
VSV-OVA.
(F) Cohorts of Tnfrsf11af/f and Tnfrsf11aDLyz2 mice were immunized with Lm-OVA and, 2 months later, challenged i.v. with VSV-OVA; expansion of OVA-specific
mCTLs (CD44+ Tet+) was measured 5 days later in spleen by flow cytometry.
Graphs represent mean ± SEM of n = 5. Statistical analysis was performed with Mann-Whitney test. *p < 0.05; ****p < 0.0001.expression by DCs (Alexandre et al., 2016; Sung et al., 2012). We
measured IFNg and CXCL9 expression in spleen from Lm-OVA-
immunized Tnfrsf11af/f and Tnfrsf11aDItgax mice 7 hr after chal-
lenge with VSV-OVA. Both IFNg and CXCL9 were significantly
reduced at this early time point in Tnfrsf11aDItgax mice upon
secondary challenge with VSV-OVA, but not after primary infec-
tion with VSV (Figure 6B), indicating that early triggering of IFNg
production by mCTLs and subsequent induction of CXCL9
expression were impaired in the absence of RANK. Analysis of
CXCL9 expression in spleen sections from VSV-challenged
mice by confocal microscopy confirmed the specific induction2522 Cell Reports 21, 2515–2527, November 28, 2017of CXCL9 expression in DCs within the MZ, which was absent
in Tnfrsf11aDItgax mice (Figure 6C). Furthermore, flow cytometry
analysis showed a significant reduction in the frequency of
CXCL9+ DCs in Tnfrsf11aDItgax mice upon VSV challenge,
compared with littermate controls (Figure 6D). These data sug-
gested that early viral replication in RANK-dependent MZMs
provided an easily accessible source of antigen and inflamma-
tory signals for triggering mCTLs by DCs, which subsequently
drives CXCL9 induction to perpetuate the memory T cell
response. To further test this hypothesis, we sought to visualize
the recruitment of mCTLs in the spleen of mice after VSV
(legend on next page)
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infection. To track the mobilization of mCTLs, we adoptively
transferred OVA-specific CD8 T cells from OT-I-GFP mice;
2 months after immunization with Lm-OVA, Tnfrsf11af/f and
Tnfrsf11aDItgax mice that had received OT-I-GFP cells were
infected with VSV-OVA, and the spleens were harvested after
7 hr. We performed confocal microscopy on spleen sections to
localize OT1-GFP cells. Mobilization of memory OT-I-GFP cells
to the splenic MZ and interfollicular regions could clearly be
seen upon VSV-OVA challenge of immunized mice (Figure 6E).
Furthermore, as expected, the recruitment of GFP-expressing
OT-I cells was reduced significantly in Tnfrsf11aDItgax mice,
which correlated with the impaired induction of IFNg and
CXCL9 expression (Figure 6B). These data demonstrate that
DC-mediated triggering of mCTLs during secondary infection
is RANK dependent.
To directly test the contribution of RANK signaling in DCs to
mCTL activation, we used OVA-conjugated monoclonal anti-
bodies to target antigen specifically to DCs in the context of
VSV infection. Lm-OVA-immunized Tnfrsf11af/f or Tnfrsf11aDItgax
micewere infectedwith wild-type VSV (not expressingOVA), and
1 hr later, OVA-conjugated anti-DEC205 (CD205) or anti-DCIR2
(CLEC4A) was injected intraperitoneally (i.p.) to target OVA spe-
cifically to DC1 (CD205+) or DC2 (CLEC4A+), respectively. Five
days later, endogenous OVA-specific mCTL expansion was
measured in spleen by flow cytometry. In wild-type mice, we
observed a strong activation of mCTL when the OVA antigen
was targeted to DC1, but not DC2 (Figure 6F), confirming the
specific role of DC1 in mCTL activation in this context. However,
recall of mCTLs was still significantly impaired in Tnfrsf11aDItgax
mice when antigen was targeted directly to DC1 (Figure 6G),
confirming that RANK signaling in DCs contributes tomCTL acti-
vation independently of antigen acquisition from MZM.
In summary, we demonstrate that RANK signaling plays crit-
ical roles in viral replication and mCTL activation in the spleen
MZ. The role of RANK is 2-fold; first, RANK expression is
required in CD169+ MZMs to provide a niche for early viral repli-
cation. Second, RANK signaling in DCs is additionally required to
propagate mCTL activation. The selective expression of RANKL
by MRCs in the spleen MZ is likely to dictate the restricted rolesFigure 6. Collaboration of MZMs and DC1 for Activation of mCTLs
(A) Frequency of RANK+ DC in spleen 7 hr after primary or secondary VSV challe
(B) Naive or Lm-OVA-immunized Tnfrsf11af/f and Tnfrsf11aDItgax mice were infec
expression were measured in total splenocytes by qRT-PCR. Data are expressed
mean ± SEM of n = 7–9.
(C) Localization of CXCL9+ DCs (green/white; filled arrowheads) in the spleen
immunized Tnfrsf11af/f and Tnfrsf11aDItgax mice 7 hr after infection with VSV-OVA
(D) CXCL9 induction in splenic DCs was measured by intracellular flow cytometr
(E) OT-I-GFP cells were adoptively transferred to cohorts of Tnfrsf11af/f and Tnfrs
infected with VSV-OVA, and spleens were collected after 7 hr for visualization of
cells (green; asterisk) in the spleenMZ is indicated, juxtaposed to RANKL+MRCs (
100 mm in the upper panels and 25 mm in the lower panels. Representative microg
quantification of OT-I-GFP clusters in Tnfrsf11af/f and Tnfrsf11aDItgax mice 7 hr af
(F) Wild-type mice were immunized with Lm-OVA and, 4 months later, challenged
DEC205, anti-DCIR2, or isotype-control antibody. Five days later, endogenous
cytometry.
(G) Lm-OVA-immunized Tnfrsf11af/f and Tnfrsf11aDItgaxmice were challenged with
mCTL expansion was measured in spleen after 5 days.
Graphs represent mean ±SEM of n = 2–6 for isotype control and n = 5–7 for the oth
0.01; ***p < 0.005.
2524 Cell Reports 21, 2515–2527, November 28, 2017of RANK in mCTL activation during infection with pathogens that
occupy this specific niche. These studies reveal an important
role for the RANKL/RANK signaling axis in the orchestration of
protective immunity during viral infection.
DISCUSSION
Macrophages and DCs are strategically located in the MZ of the
spleen at the interfacewith blood circulation where they can cap-
ture bloodborne microbes and antigens. CD169+ MZMs have
been shown to play important roles in trafficking antigens to
B cells and as a replicative niche for certain pathogens. Both
CD169+ MZMs and DCs have also been suggested to contribute
to cell-mediated immunity; however, little is known about the
mechanisms that regulate the functions of these cells during
the immune response to bloodborne pathogens and their relative
contributions to protective immunity. The RANKL/RANK
signaling axis between LTis, of hematopoietic origin, and LTos
is critical for lymphoid organogenesis. In the mature spleen,
RANKL remains constitutively expressed by MRCs, which line
the marginal sinus (Jarjour et al., 2014; Katakai et al., 2008),
but the role of RANKL/RANK signaling in the orchestration of im-
mune responses in this niche has not previously been
addressed.
We generated mice with targeted deletion of RANK (Tnfrsf11a)
in macrophages and DCs. Although previous reports had sug-
gested a role for RANK in DC survival and T cell priming (Josien
et al., 1999, 2000; Kool et al., 2011), we found no role for RANK
expression in DC homeostasis or CD8 T cell priming in the
context of infection. However, deletion of RANK expression re-
sulted in a significant defect in CD169+ MZMs. Previous reports
have shown that LT, another TNF family member, expressed by
B cells provides a maturation signal for CD169+ macrophages in
the LN sub-capsular sinus (Phan et al., 2009). However, a role of
RANKL/RANK signaling in the development or function of these
cells has never been shown. We found no defects in B cell
homeostasis after deletion of RANK expression in CD11c+ cells
(data not shown), indicating that the role of RANK in the mainte-
nance of CD169+ MZM is complementary to B cell-derived LT.nge in Tnfrsf11af/f and Tnfrsf11aDItgax mice.
ted with VSV-OVA; 7 hr after infection, induction of CXCL9 and IFNg mRNA
as fold induction compared to uninfected mice (Ctl) and are indicated as the
MZ, marked by RANKL staining (red/pink; open arrowheads), in Lm-OVA-
.
y; representative FACS plots are shown, and graph indicates mean ± SEM.
f11aDItgax mice prior to immunization with Lm-OVA. 2 months later, mice were
mCTL mobilization by confocal microscopy; recruitment of memory OT-I-GFP
red; open arrowheads) and CD11c+ DCs (blue; closed arrowheads). Scale bars:
raphs are shown from at least 2 independent experiments. Bar graph indicates
ter infection with VSV-OVA.
i.v. with wild-type VSV and administration i.p. of either OVA-conjugated anti-
OVA-specific mCTL (CD44+ Tet+) expansion was measured in spleen by flow
wild-type VSV with OVA-conjugated anti-DEC205 or isotype-control antibody;
er groups. Statistical analysis was performedwith theMann-Whitney test. **p <
The overlapping functions of RANKL and LT in the regulation of
CD169+ MZMs is reminiscent of the RANKL/LT-mediated
signaling cross-talk between LTi and LTo cells during lymphoid
organogenesis; in this case, stromal LTo cells provide RANKL
signals to amplify LT-dependent CXCL13 expression and forma-
tion of the developing LN (Brendolan and Caaman˜o, 2012).
RANKL-expressing MRCs could be considered the adult equiv-
alent of LTos (Katakai et al., 2008); thus, in mature lymphoid
organs, RANKL expressed by MRCs may have both direct ef-
fects on CD169+MZM through intrinsic RANK signaling and indi-
rect effects through the upregulation of LT expression on B cells.
Despite normal T cell priming, our data show thatRANKexpres-
sion in CD11c+ cells is specifically required for mCTL activation in
response to VSV infection and not the bacterial pathogen Lm,
which reflects the loss of RANK-dependent CD169+ MZMs that
provide a replicative niche for VSV. The lack of effect on naive
T cell priming is consistent with previous studies showing that
splenic MZMs are not required for T cell priming in the context of
VSV infection (Ciavarra et al., 1997; Junt et al., 2006). This may
reflect the differential localization of naive and memory T cells in
the spleen. Memory T cells traffic in the red pulp and patrol the
MZ (Baje´noff et al., 2010; Schenkel et al., 2014), where RANKL is
constitutively expressedby sessileMRCs (Jarjour et al., 2014; Ka-
takai et al., 2008).However, naive T cells are primed in the follicular
T cell zone requiring themigration of antigen-loadedDCs from the
MZ to the periarteriolar lymphoid sheaths (PALSs).
Although the role of CD169+ MZM in antigen transfer to B cells
is well established (Martinez-Pomares and Gordon, 2012), few
studies have addressed the role of these cells in cell-mediated
immunity. Recent studies have shown that CD169+ cells share
the capacity for cross-presentation of cell-associated antigens
to CD8 T cells with DCs (Asano et al., 2011; Bernhard et al.,
2015) but can also transfer antigen to DC1 for cross-presentation
(Backer et al., 2010). RANK deletion in lysozyme M (Lyz2)-ex-
pressing cells, which includes CD11c+ macrophages but not
DC1, resulted in the loss of CD169+ MZMs but did not impair
mCTL recall, implying that RANK function in CD11c+ cells other
thanMZMs contributes tomCTL activation. DCs have previously
been shown to be required for mCTL activation upon infection
with bacterial and viral pathogens (Zammit et al., 2005). How-
ever, these studies utilized CD11c-DTR mice, in which both
DCs and CD169+ macrophages are lost (Bernhard et al., 2015;
Probst et al., 2005). A more recent study showed that XCR1+
DC1s are specifically required for mCTL activation in response
to certain pathogens, including VSV (Alexandre et al., 2016).
We showed that acquisition of VSV by DC1 in the spleen was
significantly reduced after RANK deletion in CD11c+ cells. Since
DC1 numbers were not affected upon RANK deletion, this
implies that VSV is transferred to DC1 via RANK-dependent
MZMs. However, antigen targeted directly to DC1 still required
RANK signaling for full activation of mCTLs, suggesting that
RANK contributes to mCTL activation by DC1 independently of
antigen transfer from MZMs. RANK signaling significantly
increased antigen-specific CD8 T cell activation by DC in vitro
in response to exogenous antigen, suggesting that RANKL/
RANK signaling in the MZ may increase DC functionality and
activation of mCTLs. In addition, RANKL can induce interleukin
(IL)-12 and IL-15 expression in DCs (Josien et al., 1999), whichare known to play important roles in the propagation of mCTL re-
sponses (Alexandre et al., 2016). The localized expression of
RANKL in the MZ may, therefore, restrict the effects of RANK
signaling to DCs in this specific niche and may even have a
role in retention of RANK+ DCs, thus favoring the activation of
mCTLs and not the priming of naive T cells by migratory DCs.
In summary, we describe an important role for the RANKL/
RANK signaling axis in the orchestration of macrophage and
DC activation during the immune response to viral infection.
RANK-dependent CD169+ MZMs represent a niche for viral
replication, and RANK signaling in DCs coordinately regulates
mCTL recruitment and activation to propagate the immune
response. These studies reveal new insights into how protective
immunity to viral infection is triggered in the spleen MZ and the
importance of RANK signaling in this specific niche.
EXPERIMENTAL PROCEDURES
Mice
Experiments were conducted in strict accordance with good animal practice
according to French animal welfare bodies and the European Convention
(EEC Directive 86/609) and were approved by the Direction De´partmentale
des Services Ve´te´rinaires des Bouches du Rho^nes. Tnfrsf11af/f mice (Hanada
et al., 2009) were crossed with Tg(Itgax-Cre) mice (Caton et al., 2007) or
Lyz2Cre/+ mice (Clausen et al., 1999) and subsequently backcrossed to wild-
type C57Bl6/J mice for >12 generations. B6.Rag2tm1Fwa (Rag2/),
B6.Rag2tm1FwaTg(TcraTcrb)1100Mjb (OT-I) mice were purchased from Taconic
Biosciences. OT-I-EGFP mice have been previously described (Baje´noff
et al., 2010). B6.SJL-Ptprca Pep3b/BoyJ (CD45.1+) mice were purchased
from The Jackson Laboratory. CD45.1+ mice were crossed with wild-type
B6 mice (CD45.2+) to generate CD45.1+/CD45.2+ mice for adoptive transfer
experiments. Rosa26lsl-tdRFP mice and Tg(Itgax-YFP) mice have previously
been described (Lindquist et al., 2004; Luche et al., 2007).
Virus and Bacteria
Recombinant VSV-OVA (Franck et al., 2012), recombinant Lm-OVA (Baje´noff
et al., 2010), and VSV-EGFP (Iannacone et al., 2010) were kindly provided by
L. Lefrancois, G. Lauvau, and J. Cunningham, respectively. VSV-EGFP was
propagated at an MOI of 0.01 on BHK cells and purified as described previ-
ously (Franck et al., 2012; Iannacone et al., 2010). VSV titers from spleen
were determined as described previously (Junt et al., 2007).
Preparation of OVA-Conjugated Monoclonal Antibodies
Purified rat immunoglobulin (Ig)G2a antibodies anti-CD169 (MOMA-1), anti-
DEC205 (NLDC145), anti-DCIR2 (33D1), and isotype control (R7D4) were pre-
pared as described previously (Backer et al., 2010).
Infections and Immunization
Mice were anesthetized using ketamine/xylazine before epicutaneous treat-
ment with 62.5 mg 5% Aldara cream (IMQ; 3M Pharmaceuticals) and subcu-
taneous (s.c.) injection of 30 mL EndoGrade endotoxin-free chicken OVA
(Hyglos) diluted in PBS (2 mg/mL). Primary infections with Lm-OVA (Baje´noff
et al., 2010), VSV-OVA (Franck et al., 2012), or VSV-EGFP (Iannacone et al.,
2010) were performed i.v.; Lm-OVA was grown to log phase in BD Bacto Brain
Heart Infusion Broth (BHI; BD Biosciences ref. 237500), bacteria were washed
in PBS, and 13 104 CFUs were injected per mouse. VSV-OVA and VSV-EGFP
were injected at 105 or 106 PFUs per mouse. Secondary challenges were per-
formed at least 2 months after IMQ/OVA immunization or primary Lm-OVA
infection. OVA-conjugated monoclonal antibodies (Backer et al., 2010) were
injected i.p. 1 hr after VSV infection.
Antibodies
Anti-CD3e (145-2C11), anti-CD11c (HL3), anti-CD4 (RM4-5), anti-CD8a (53-
6.7), anti-CD11b (M1/70), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD45.2Cell Reports 21, 2515–2527, November 28, 2017 2525
(104), anti-CD45R (B220) (RA3-6B2), anti-CD40 (3/23), anti-CD254 (RANKL)
(IK22-5), anti-CD265 (RANK) (R12-31), anti-CD169 (MOMA-A), anit-SIGN-R1
(ER-TR9), anti-B220 (RA3-6B2), anti-NK1.1 (PK136), anti-IFNg (XMG1.2),
anti-Granzyme B (FGB12), anti-CXCL9 (MIG-2F5.5), anti-Ly6C (AL-21), and
anti-MHCII (M5/114) were purchased from BD Biosciences, eBioscience,
BioLegend, and Life Technologies. H-2Kb-OVA257264 PE tetramers were
purchased from Beckman Coulter Genomics.
Flow Cytometry
Single-cell suspensions from LNs or spleen were first incubated at 4C for
10 min with the 2.4.G2 antibody to block Fc receptors and then stained with
the indicated antibodies for 30 min at 4C. Dead cells were gated out using
SYTOX Blue dead cell stain (Life Technlogies, ref. S34857). For IFNg and
GrzB intracellular staining, spleen cells were stimulated with either 10 mM
OVA257–264/OVA323–339 or ionomycin and phorbol 12-myristate 13-acetate
(PMA) in RPMI 1640 medium containing 10% fetal calf serum (FCS) and
GolgiStop (BD Biosciences) for 4 hr. After cell-surface staining, cells were
fixed, permeabilized, and washed with BD Cytofix/Cytoperm or BD
Perm/Wash buffer (BD Biosciences, ref. 554723/554722). Cells were then
incubated with IFNg and GrzB antibodies diluted in Perm/Wash buffer for
30min at 4C. Analysis was performed using BD FACSCanto or LSR-2 flow cy-
tometers (BD Biosciences), and data analysis was conducted with the FlowJo
cytometric analytical software (Tree Star).
Immunofluorescence Microscopy
Mice were killed 7 hr post-infection, and spleen was harvested and fixed for
4 hr in Antigenfix (DiaPath, MM France) at 4C, washed in phosphate buffer
(GIBCO, ref. 14190-094) for 1 hr, dehydrated in 30% sucrose overnight at
4C, and embedded in optimum cutting temperature medium (OCT) freezing
media (Tussue-Tek, ref. 4583). Spleen sections were blocked for 1 hr in 2%
BSA before incubation with primary antibodies for at least 1 hr or overnight, de-
pending on the antibodies. Stained spleen sections were then mounted in
ProLong Gold antifade reagent with DAPI (Life Technologies, ref. P36931)
and analyzed by confocal microscopy using the Zeiss LSM 780. Quantification
of colored pixels was performed using ImageJ software. OT-I cell clustering
was defined as a group of 3 or more proximate cells. The proportion of clus-
tered cells was quantified according to the total number of OT-I GFP cells pre-
sent on the whole section. The limits of the MZ region were determined with
nuclear density and RANKL expression by MRCs lining the MZ. Staining was
quantified only in the MZ by manual separation using ROI Manager tools in
ImageJ. The same regions from each section were applied to all channels after
specification of the limit threshold intensity for each channel. The mean gray
value for all channels was measured using the ROI Manager tool.
Statistical Analysis
p values were calculated using either the Mann-Whitney test or the Fisher test,
where appropriate, using GraphPad prism software. p values are indicated as:
*p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001.
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Figure S1. Detailed gating strategy for DC subsets, related to Figure 1. (A) gating strategy for DC1 
(CD8a+), DC2 (CD11b+) and pDC (SiglecH+) subsets in spleen (A) and lymph node (B).  
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Figure S2. RANK expression by CD11c+ cells regulates memory CD8 T cell activation in response to viral 
infection, related to Figure 2. (A) Tnfrsf11af/f  and Tnfrsf11aΔItgax mice were infected i.v. with 1x104 Cfu Lm-
OVA or 1x105 Pfu VSV-OVA; 1 week later blood was collected and granzyme B (GrzB) production by was 
measured in CD8+ T cells by intracellular cytokine staining (ICS), after ex vivo stimulation with cognate peptide 
(SIINFEKL). (B-C) Cohorts of Tnfrsf11af/f  and Tnfrsf11aΔItgax mice were immunized with Lm-OVA, IMQ/OVA 
or VSV-OVA; 2 months later mice were challenged with either VSV-OVA (B) or Lm-OVA (C), 5 days later, 
IFNg and GrzB production were measured in spleen CD8+ T cells by ICS, after ex vivo stimulation with 
SIINFEKL. Data are represented as mean ± s.e.m. and statistical analysis was performed with Mann–Whitney 
test; **p=<0.01, ***p=<0.005. 
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Figure S3. RANK in CD11c+ cells is not required for the development of pathogen-specific mCTL, related 
to Figure 2. (A-B) Cohorts of Tnfrsf11af/f  and Tnfrsf11aΔItgax mice were immunized with IMQ/OVA (A) or Lm-
OVA (B); 2 months later spleen cells were analysed by FACS for expansion of OVA-specific memory CD8 T 
cells (CD44+ Tet+) and IFNγ or GrzB expressing cells upon activation with SIINFEKL. Data are represented as 
mean ± s.e.m. 
 
 
Figure S4. RANK in CD11c+ cells regulates activation of adoptively transferred memory CD8 T cells, 
related to Figure 2. (A-B) CD45.1+ mice were immunized with Lm-OVA, 3 weeks later CD4 and CD8 T cells 
were isolated from spleen and adoptively transferred to cohorts of naïve Tnfrsf11af/f  and Tnfrsf11aΔItgax mice, a 
further 7 weeks after T cell transfer mice were infected with VSV-OVA (A) or Lm-OVA (B); IFNγ and GrzB 
expression in adoptively transferred mCTL (CD44+, CD45.1+) and endogenous naïve CD8 T cells (CD45.2+) 
cells was measured 5 days after challenge in spleen, after stimulation with cognate peptide (SIINFEKL). Data 
are represented as mean ± s.e.m. and statistical analysis was performed with Mann–Whitney test; **p=<0.01. 
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Figure S5. RANK expression in DC from Tnfrsf11aΔLyz2 mice, related to Figure 5. (A) Spleen sections from 
Rosa26-LSL-tdRFP x Lyz2cre/+ mice showing Cre-recombinase activity in CD169+ cells; tdRFP (red) and CD169 
(green). Scale bars; 50 µm in upper panels and 25 µm in lower panels. (B) RANK expression on DC (MHC-IIhi 
CD11c+) was measured by flow cytometry in CLN from Tnfrsf11af/f, Tnfrsf11aΔLyz2 and Tnfrsf11aΔItgax mice with 
and without IMQ treatment, representative FACs plots are shown. (B) Total number of DC were quantified. 
Representative data from at least 2 independent experiments are shown.  
 
 
Figure S6. RANKL increases cross-presenting activity by DC in vitro, related to Figure 6. (A-B) Bone 
marrow-derived DC (BMDC) for wild-type mice (A-B), or Tnfrsf11af/f  and Tnfrsf11aΔItgax mice (C), were co-
cultured with mouse fibroblasts expressing RANKL (3T3-RANKL), control cells (Ctl) or 100ng/ml LPS, before 
loading with recombinant OVA and addition of CFSE labeled OVA-specific T cells (OT-1). After 3 days, CFSE 
dilution was analysed by flow cytometry and the number of proliferating OT-1 cells quantified. IFNγ production 
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by OT-1 cells was measured by ELISA. Data are represented as mean ± s.e.m. of cumulative data from 3 
independent experiments. 
 
 
Supplementary experimental procedures. 
 
Generation of RANKL expressing stromal cells and cross-presentation assays. 
3T3-RANKL cell line was generated as described by Sarrazin et al. (Sarrazin et al., 2009). Briefly, MSCV-based 
retroviral vectors were constructed by PCR cloning of cDNA for mouse RANKL under LTR control and by 
replacement of the IRES-driven GFP to generate RANKL-GFP. Viral supernatants was produced with ϕNXe 
cells (http://www.stanford.edu/group/nolan) and used to infect 3T3 cells by a double spin infection for 2 h in the 
presence of 8 mg/ml polybrene. Bone marrow-derived dendritic cells (BMDC) were generated according to the 
Steinman protocol (Inaba et al., 1992) . Briefly, cells were cultured with 20 ng/ml recombinant mouse GM-CSF 
(Peprotech) the medium was changed at day 2 and 4 with fresh medium supplemented with GM-CSF. BMDC 
were collected at day 6 and co-cultured overnight on top of 3T3-RANKL or Ctl cells at a ratio 45:1. Non-
adherent DC were harvested and washed before incubation with recombinant OVA in culture medium for 1-2 
hours. DC were then washed extensively with culture medium before addition of OT-1 T cells labelled with 
CFSE at a ratio 1:3 for 2.5 days, CFSE dilution as an index of T cell proliferation was analysed by flow 
cytometry. 
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